The type I interferons (IFNs) bind surface receptors, induce JAK kinases and activate STAT transcription factors to stimulate the transcription of genes downstream of IFN-stimulated response elements (ISREs). In this study, we demonstrate that IFNaR2, a subunit of the type I IFN receptor, is proteolytically cleaved in a regulated manner. Immunoblotting shows that multi-step cleavage occurs in response to phorbol ester (PMA) and IFN-a, generating both a transmembrane 'stub' and the intracellular domain (ICD), similar to Notch proteolysis. Isolated membrane fractions process IFNaR2 to release the ICD. A chimeric receptor construct is utilized to show that cleavage requires the presenilins and occurs in response to epidermal growth factor and protein kinase C-d overexpression, as well as PMA and type I IFNs. Fluorescence microscopy demonstrates that a green fluorescent protein-ICD fusion localizes predominantly to the nucleus. A fusion between the ICD and the Gal4 DNA-binding domain represses transcription, in a histone deacetylasedependent manner, of a Gal4 upstream activating sequence-regulated reporter, while overexpression of the ICD alone represses transcription of a reporter linked to an ISRE. Proteolytic cleavage events may facilitate receptor turnover or, more likely, function as a mechanism for signaling similar to that employed by Notch and the Alzheimer's precursor protein.
Introduction
Receptors for the large family of helical cytokines, which include the interferons (IFNs), utilize JAK tyrosine kinases and STAT transcription factors to modulate gene transcription (Levy and Darnell, 2002) . The JAKs bind constitutively to receptor subunits, are activated when ligand binding dimerizes the receptor subunits and sequentially phosphorylate multiple components of the signaling cascade. In the case of the type I IFNs, including IFN-a and -b, ligand binding to the IFNaR1 and IFNaR2 receptor subunits juxtaposes and activates Tyk2 and Jak1, the associated JAK kinases (Colamonici et al., 1994; Domanski et al., 1995; Yan et al., 1996b) . The JAKs become phosphorylated, and in turn phosphorylate a critical tyrosine on IFNaR1, which functions as a docking site for the Stat2 SH2 domain (Yan et al., 1996a; Li et al., 1997 ). Subsequently, Stat2 and then Stat1 are phosphorylated, heterodimerize and translocate to the nucleus to stimulate transcription.
Regulated intramembrane proteolysis (RIP) has emerged as a mechanistically simple and evolutionarily conserved mechanism for relaying a signal from a membrane surface to the nucleus (Brown et al., 2000) . An initial, regulated cleavage within a juxtamembrane (JM) region of the extracellular domain releases the extracellular domain. The residual membrane-bound 'stub' is further processed by an intramembrane (IM) protease, releasing the intracellular domain (ICD), which translocates to the nucleus and modulates gene transcription or other biological activities (Weihofen and Martoglio, 2003) . For many of the known eukaryotic RIP substrates, intramembrane proteolysis is catalysed by g-secretase, a multi-protein complex which includes one or both of the presenilin proteases (Capell et al., 1998; Yu et al., 1998; Li et al., 2000; Esler et al., 2002; Takasugi et al., 2002) and a set of associated proteins (Edbauer et al., 2003; Kimberly et al., 2003; Takasugi et al., 2003) . Some membrane proteins, such as sterol regulatory element binding protein 2 (SREBP-2) and Notch, appear to signal primarily via the RIP mechanism. The ICD can function to modulate gene transcription via direct DNA binding (SREBP-2) or by interacting with DNA-bound protein complexes (Notch). The receptor type tyrosine kinases HER4 (Ni et al., 2001 ) and the M-CSF-1 receptor (Wilhelmsen and van der Geer, 2004) can be cleaved in a regulated manner resembling RIP, suggesting that these molecules might signal via canonical tyrosine kinase-driven mechanisms as well as RIP-mediated mechanisms. Thus, we sought to determine whether a member of the helical cytokine receptor family might be similarly processed. Our results demonstrate that IFNaR2 can be cleaved in response to IFN-a and other stimuli, including activated protein kinase C-d (PKCd), and that the IFNaR2 ICD is capable of nuclear translocation and transcriptional modulation.
Results

Proteolytic cleavage of IFNaR2
To investigate IFNaR2 processing, we exploited the observation that phorbol ester can activate the metalloprotease TACE, which is known to mediate the initial regulated JM cleavage event in the RIP signaling of HER4 (Rio et al., 2000) , as well as other transmembrane proteins (Okamoto et al., 1999; May et al., 2002) . U5A cells, which do not express the IFNaR2 subunit of the IFN-a receptor (Lutfalla et al., 1995) , were stably transfected with an IFNaR2-hemagluttinin (HA) construct containing an HA epitope tag at the extreme carboxyl terminus . A stable transfectant expressing IFNaR2 was treated with phorbol ester for varying times and extracts were immunoblotted with an anti-HA antibody. A number of novel bands migrating at approximately 58, 40, 34 and 27 kDa (faint) were detected ( Figure 1a) .
To characterize the PMA-generated IFNaR2 fragments, we transiently expressed the three constructs shown in Figure 1b : the full-length IFNaR2-HA construct used in Figure 1a (FL), and two variants in which large portions of the extracellular domain have been deleted (E1 and E2). These HEK293T cell transfectants were treated with PMA, separated into plasma membrane and cytosolic fractions and immunoblotted with an anti-HA antibody. The membrane fraction from cells expressing the full-length receptor contained both the 97 kDa intact receptor and a 58 kDa cleavage product (Figure 1c , lane 4). Reprobing with an anti-EF2 antibody (Figure 1c, lower panel) indicates that the membrane fraction was essentially free of cytoplasm (EF2 is cytoplasmic). To determine the Figure 1 Proteolytic cleavage of IFNaR2. (a) PMA-dependent cleavage of IFNaR2. U5A cells stably expressing an IFNaR2 gene containing a carboxyl-terminal HA tag were treated with 100 ng PMA/ml for the indicated time (min) and lysed with 1% NP40. The lysate was centrifuged and the supernatant was immunoblotted and probed with an anti-HA antibody. The approximate sizes of various fragments are indicated. Probing of nontransfected lysates confirmed that all of the observed bands were IFNaR2-specific (data not shown). (b) IFNaR2 constructs used in (c). The fulllength (FL) construct and two internally deleted variants (E1 and E2) are shown. The amino terminus is at the top, followed by the signal sequence, corresponding to residues 1-28 (gray rectangle). The black rectangle in the middle represents the transmembrane domain (residues 244-264) and gray oval represents the carboxylterminal HA tag. In E1, residues 45-219 were deleted and a FLAG tag inserted. In E2, residues 33-232 were deleted. (c) Subcellular localization of IFNaR2 cleavage products. HEK293T cells were transfected with plasmids encoding the IFNaR2 constructs depicted in (b). After 2 days, proteins were extracted as in (a) (M þ C), or from separate cell membrane (M) or cytosolic (C) fractions. (d) IFNaR2 cleavage in isolated membranes. U5A cells stably expressing IFNaR2-HA were treated with PMA for 90 min, membrane preparations were prepared as detailed in Materials and methods and subsequently incubated for 2 h at the indicated temperature. Following in vitro incubation, the membrane preparations were centrifuged and the pellet (Mem) and supernatant (Sup) fractions immunoblotted and probed with anti-HA antibody IFNaR2 receptor proteolysis AZM Saleh et al approximate location of the cleavage site, we compared the migration of the FL, E1 and E2 constructs. The 58 kDa band generated from FL IFNaR2 (lane 4) comigrates with the E2 deletion construct (lane 6), suggesting that IFNaR2 has been cleaved near residue 233. Construct E1 encodes a protein that is 33 amino acids longer than E2 and clearly migrates more slowly (lane 5). Thus, the initial (JM) cleavage event which removes the bulk of the ecto-domain occurs in the vicinity of residue 233, which is about 11 amino acids proximal to the amino terminus of the predicted IFNaR2 transmembrane domain. Examination of the cytosolic fraction indicates that a 34 kDa protein is generated from all the three IFNaR2 constructs (lanes 7-9). The B40 kDa band observed in Figure 1a is only weakly detected in this experiment. The presence of the 34 kDa bands in the cytosol of the E1 and E2 constructs is consistent with the idea that constructs which are engineered to resemble membrane-bound 'stubs' are constitutively processed by an IM protease to release the corresponding ICD (Struhl and Greenwald, 2001; LaVoie and Selkoe, 2003) . A 27 kDa fragment is also detected in the cytosol of the FL construct (lane 7). In nuclear fractions from cells transfected with the FL and E2 constructs, both the 27 and 34 kDa bands were observed, with the 27 kDa more prominent (AE and JJK, unpublished results).
To further investigate the IM cleavage of IFNaR2, cells employed in Figure 1a were treated with PMA and the partially purified plasma membrane preparations were incubated at either 4 or 371. These membrane fractions are expected to contain full-length IFNaR2, the 55 kDa 'stub' and the putative processing proteases. Following incubation, membranes were pelleted and the companion supernatants, containing soluble proteins released by intramembrane proteolysis, were collected. Proteins from the pelletted membranes (Mem) as well as the supernatant (Sup) were immunoblotted with anti-HA antibody. In the supernatant fraction, we observed that a 34 kDa protein was generated more efficiently at 371, relative to 41 (Figure 1d , lane 8), consistent with proteolytic cleavage of the IFNaR2 transmembrane domain by protease(s) residing in the plasma membrane. As in Figure 1c (lane 7), a less abundant 27 kDa protein also increases following incubation at 371. In addition, there is a decrease in the amount of full-length IFNaR2 (compare lanes 1 and 2). There is a small amount of the 58 kDa protein that corresponds to the JM cleavage product (lanes 5-6).
To determine if a physiologic ligand for the type I IFN receptor could induce IFNaR2 cleavage, we treated the U5A-IFNaR2-HA cells used in Figure 1a with IFNa2 for up to 2 h and immunoblotted the extracts using an anti-HA antibody (Figure 2a ). The level of the fulllength IFNaR2 protein declined in a time-dependent fashion, indicating that IFN-a activated the proteolytic process. A second immunoblot of the same lysates, containing 10-fold more protein, demonstrated an IFNa-dependent increase in the various cleavage products, including the 58, 40 and 34 kDa species. We generated additional U5A-IFNaR2-HA-transfected cell lines, and selected two that expressed considerably lower levels of IFNaR2-HA. Specifically, the lines examined in Figures  2b and c expressed IFNaR2-HA at about 10 and 3% of the level of expression observed in the line used in Figure 2a (data not shown). Both of these lines also display IFN-a-dependent reduction of full-length IFNaR2 as well as production of the 35 kDa cleavage product (Figure 2b, c) . 
Presenilins effect IFNaR2 cleavage
To further characterize IFNaR2 cleavage, we constructed a 'cleavage reporter' in which most of the ICD of IFNaR2 was replaced by a Gal4DBD-VP16 transactivation domain (TAD) fusion sequence ( Figure 3a ) (Karlstrom et al., 2002; May et al., 2002) . Intramembrane cleavage of this protein (I2-ECD-GV) releases the Gal4-VP16 fusion protein fragment, which in turn translocates to the nucleus and stimulates transcription of a co-transfected luciferase gene under the control of an element that binds the Gal4DBD. Figure 3b demonstrates that one or both presenilin gene products mediate proteolytic cleavage of I2-ECD-GV. Specifically, a set of CHO cell derivatives (Kimberly et al., 2000) stably expressing either wild-type presenilin 1 (PS1) or various mutant forms of PS1 or PS2 were transiently transfected with pMT-I2-ECD-GV (or vector) and pG4-thymidine kinase (TK)luc, which encodes a luciferase gene under the control of a Gal4 upstream activating sequence (UAS). CHO cells expressing wildtype PS1 show a significant increase in luciferase activity compared to cells receiving vector DNA. In contrast, cells expressing a catalytically inactive version of PS1, in which a critical aspartate residue has been converted to alanine, reveal reduced cleavage activity. Cells coexpressing catalytically inactive versions of both PS1 and PS2 do not cleave the IFNaR2 reporter construct at all, relative to control cells transfected with vector DNA. Some individuals afflicted with familial Alzheimer's disease (FAD) have germline mutations in the PS1 gene (Cruts and Van Broeckhoven, 1998) , which appear to alter the pattern of intramembrane cleavage of the Alzheimer's precursor protein (APP). When the plasmid encoding I2-ECD-GV was transfected into CHO cells expressing the M146V FAD mutant of PS1, cleavage was reduced, relative to cells expressing wild-type PS1.
Multiple effectors of IFNaR2 cleavage
To confirm and extend the cleavage data in Figures 
PKCd regulates IFNaR2 cleavage
To investigate the possibility that PKCd, which is induced by IFN-a (Uddin et al., 2002) , mediates the is mediated by PS1 and PS2. CHO cell lines stably expressing wildtype presenilin 1 (PS1wt); a mutant form of PS1 found in individuals with FAD, in which the methionine at position 146 has been replaced by valine; a mutant form of PS1 in which aspartic acid 257 has been converted to alanine (PS1D257A); or both mutant PS1D257A and an analogous mutant of PS2 in which aspartic acid 366 has been converted to alanine (PS1D257A þ PS2D366A), were transiently transfected with pMT-I2-ECD-GV ( þ ) or pMT2T (À) plasmids as indicated, as well as pG4-TKluc and pRL-TK (transfection efficiency control). After 2 days, luciferase activities were measured and normalized as described in Materials and methods
Figure 4
Type I IFNs, PMA and EGF stimulate intramembrane cleavage of IFNaR2. HEK293T cells were transfected with pMT-I2-ECD-GV ( þ ) or pMT2T (À) plasmids, as well as pG4-TKluc and pRL-TK. After 1 day, cells were left untreated (None), or treated with 3000 U/ml of either IFN-a or IFN-b, 100 ng/ml PMA, both PMA and IFN-a, or 20 ng/ml EGF. After 24 h, luciferase activities were measured and normalized as described in Materials and methods (Figure 6a ). Rottlerin, which is a PKC-dspecific inhibitor at low concentrations (Gschwendt et al., 1994) , was also able to inhibit cleavage ( Figure 6b ). The inhibitor Go¨6976, which targets classical PKC proteins (Martiny-Baron et al., 1993) (PKCa, bI, bII and g), had no effect (Figure 6c ). The g-secretase inhibitor H5106 blocks PKCd-mediated cleavage of I2-ECD-GV, again indicating that the molecular mechanism involves intramembrane proteolysis ( Figure 7 ).
Nuclear localization of the IFNaR2 ICD
To investigate the ability of the IFNaR2 ICD to translocate to the nucleus, U2OS cells were transfected with a construct encoding a green fluorescent protein (GFP)-ICD fusion (GFP-I2-ICD). A GFP-HER2-ICD construct, known to localize primarily to the cytoplasm (Ni et al., 2001) , was employed in a parallel, control transfection. Figure 8 shows that the GFP-I2-ICD was predominantly seen in the nucleus. When unfused GFP was expressed in the same cells, green fluorescence was detected throughout the cell, albeit somewhat more intensely in the nucleus (data not shown). However, the ratio of nuclear to cytoplasmic fluorescence was substantially greater in the cells transfected with GFP-I2-ICD, relative to those expressing unfused GFP. Interestingly, we observed relatively few green fluorescent cells in the culture transfected with GFP-I2-ICD compared to the GFP-HER2-ICD control (data not shown). This is consistent with the finding that ICDs are relatively labile (Brown et al., 2000) . After 2 days, luciferase activities were measured and normalized as described in Materials and methods
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The IFNaR2 ICD represses gene transcription
Given that IFNaR2 can be proteolysed to generate an ICD-sized fragment, and that this fragment is capable of nuclear translocation, we sought to determine if the putative IFNaR2 ICD could modulate gene transcription. Initially, we tested the transcriptional effects of the IFNaR2 ICD by fusing this fragment to the Gal4DBD. The resulting construct (Gal4-I2-ICD) was transfected, along with a Gal4 UAS-regulated luciferase reporter gene, into U2OS cells and reporter gene activity was assayed. Surprisingly, Gal4-I2-ICD repressed reporter gene activity, relative to cells transfected with the Gal4DBD construct alone (Figure 9a ). All other previously characterized ICDs produced by RIP have been shown to enhance transcription (Ebinu and Yanker, 2002) . The ability of the IFNaR2 ICD to repress gene transcription is dependent on the amount Figure 7 Effect of g-secretase inhibitor on PKC-mediated cleavage of IFNaR2. Similar to Figure 6 , except that the inhibitor H5106 was added at the indicated concentration To test the possibility that one or more HDAC proteins mediate the observed repression, we repeated the experiments shown in Figure 9a in the presence of varying concentrations of trichostatin A (TSA), an HDAC inhibitor (Yoshida et al., 1990) . Figure 10 demonstrates that increasing concentrations of TSA relieve the transcriptional repression produced by Gal4-I2-ICD, suggesting that one or more of the HDAC proteins are involved in these inhibitory events.
To determine if the IFNaR2 ICD can modulate transcription from the ISRE, U5A cells were transiently transfected, pairwise, with either a plasmid expressing an open reading frame corresponding to the ICD or the corresponding vector, and either an ISRE-linked luciferase reporter or the corresponding vector (see Materials and methods). In this set of reporter assays, the transcriptional effect of the ICD on an ISRE linked to a minimal TK promoter was normalized to its effect on the minimal promoter alone. Thus, Figure 11 shows the effect of either an empty vector (left column) or the IFNaR2 ICD (right column) on an ISRE-luciferase reporter relative to the effect on the companion luciferase reporter plasmid containing only a minimal promoter. As was the case with the Gal4DBD-I2-ICD fusion, the isolated ICD repressed transcription from a reporter construct containing a response element linked to a minimal TK promoter.
Discussion
Intracellular signaling events, often depicted as linear cascades, are biochemically complex, involving crosstalk and feedback control as well as multiple mechanisms for initiation. RIP signaling is an ancient mechanism for relaying signals from the cell surface to the interior of the cell. In the case of membrane proteins such as SREBP-2, Notch and APP, intramembrane proteolysis appears to represent the only mechanism of signal initiation. In contrast, the recent discoveries that HER4 and the M-CSF-1 receptor, two receptor-type tyrosine kinases, undergo RIP in response to ligand binding suggests that some membrane proteins might signal via intramembrane proteolysis of the ICD as well as, or in lieu of, well-established mechanisms involving kinase activation. We now provide additional evidence in support of this possibility, by demonstrating that the The data from the three sets of transfected cells were re-plotted as percent repression, as a function of TSA concentration. TSA increased the transfection efficiency of the constitutively expressed b-galactosidase construct in a dose-dependent manner. Thus, the levels of normalized luciferase activity are higher in those cultures receiving TSA relative to the control cultures Figure 11 The IFNaR2 ICD represses transcription of an ISRE reporter. U5A cells were transfected as described in Materials and methods and subsequently assayed for luciferase activities. Cultures were transfected either with constructs encoding the IFNaR2 ICD (left) or the corresponding vector (right). Each firefly luciferase value was normalized by dividing by the corresponding Renilla luciferase value. The normalized luciferase value obtained from cells transfected with the ISRE-luc construct was divided by the normalized luciferase value for cells receiving pGL3 vector (Buxbaum et al., 1998; Rio et al., 2000; Black, 2002; Weskamp et al., 2004) , generates a membrane stub of IFNaR2 (Figure 1) as well as smaller fragments localized to the cytoplasm and nucleus. Co-migration with ecto-domain deletion derivatives indicates that the larger (B58 kDa) cleavage product is a membrane stub (Figure 1c) . Based on primary amino-acid sequence data, the E2 extracellular domain deletion derivative (Figure 1c, lanes 3 and 6) should have a molecular mass of B36 kDa. The apparent larger size of B58 kDa may be due to posttranslational modification. Recent NMR structural studies of IFNaR2 indicate that the region containing the cleavage site predicted by our data lies immediately distal to a well-defined fibronectin-like domain of the IFNaR2 ectodomain, within a short, stalk-like juxtamembrane region (Chill et al., 2003) . Similarly, the TACE cleavage site in the growth hormone receptor also resides in a structurally similar JM region (Baumann and Frank, 2002 ). It appears that both stalk length and sequence are critical determinants of TACE cleavage (Hinkle et al., 2004) . Further experimentation is needed to determine whether TACE is indeed responsible for JM cleavage of IFNaR2, and to determine the actual cleavage site.
In addition, membrane-bound IFNaR2 can be processed in vitro, in a constitutive fashion, to yield soluble fragments (Figure 1d ), consistent with our suggestion that the responsible protease is in the plasma membrane. These fragments (34 and 29 kDa) are identical in size to those seen in the cytosol of PMAtreated cells (Figure 1c) . If the intramembrane cleavage occurs near the carboxyl terminus of the transmembrane domain, the IFNaR2 ICD is predicted to have a mass of 27 kDa. Thus, as noted for the 58 kDa JM-cleavage product, the 35 kDa fragment might be a post-translationally modified version of the ICD. Alternatively, cleavage may occur at multiple positions within the transmembrane domain, as has been observed for APP (De Strooper et al., 1999; Okochi et al., 2002) as well as other PS substrates (Xia and Wolfe, 2003) . Protein sequencing of the cleavage products will define the site(s) of cleavage.
Our studies identified multiple stimuli that are capable of activating proteolysis of IFNaR2. Specifically, cleavage occurs constitutively when cells are grown in mitogen-rich media (for example, Figure 2a , lane 1 and the columns labeled 'none' in Figure 4 ). Such basal cleavage was also observed in serum-starved cells (data not shown). Constitutive cleavage is frequently observed for shed proteins and, in the case of TNFa, has been blocked by inhibiting p38 MAP kinase signaling (Fan and Derynck, 1999) . PMA (Figures 1 and 4) , which induces multiple PKC isoforms as well as TACE, and EGF (Figure 4 ) also induce IFNaR2 cleavage. These observations suggest that if regulated proteolysis of IFNaR2 does stimulate intracellular signaling, there is ample opportunity for crosstalk with other signaling mechanisms.
Importantly, two type I IFNs, IFN-a and IFN-b, can also stimulate IFNaR2 cleavage, as indicated by both the immunoblotting studies (Figure 2 ) and the cleavable reporter assay (Figure 4) . We observed IFN-stimulated cleavage in transfected cells expressing significantly different levels of the receptor subunit (Figure 2) . Although at this point we are uncertain how the levels of exogenous IFNaR2 in the various lines examined compare to endogenous levels in typical cells, our data argue that IFN-mediated cleavage is not simply an artifact of overexpression. The kinetics of cleavage are distinct from those observed for the tyrosine phosphorylation of JAK-STAT components following IFN treatment of the same cells. Specifically, tyrosine phosphorylation typically reaches a maximum within the first half-hour following ligand treatment (Colamonici et al., 1994) , while we observed a continuing increase in proteolysis beyond 1 h (Figure 2 ). The amount of the ICD generated in response to IFN treatment appears to be less than the extent of 97 kDa cleavage. There are a number of possible explanations for this observation, including rapid translocation to the nucleus and the fact that RIP substrates are relatively labile. The full-length protein might also undergo lysosomal degradation (Kumar et al., 2003) . We also observed less of the 58 kDa stub in U5A cells relative to HEK293T cells following treatment with PMA (Figure 1) , as well as in the absence of treatment (data not shown). This may be due to differences between these cell lines in the relative efficiency or extent of induction of one or both proteases involved in IFNaR2 processing.
PMA and IFN-a2 effects on cleavage are not additive (Figure 4) , suggesting that these agents act through similar, rather than complementary, signaling pathways. It has been reported that PKCd activity is induced by IFN-a (Uddin et al., 2002) . Consistent with this observation, we found that overexpression of PKCd was able to induce IFNaR2 cleavage ( Figure 5 ) and that this effect could be blocked by specific PKC inhibitors ( Figure 6 ). The possible role of PKC in IFNaR2 RIP is further strengthened by our finding that EGF, an activator of PKC (Rhee, 2001) , can also stimulate cleavage of the IFNaR2 reporter (Figure 4) . However, the molecular apparatus linking IFN-a and PKCd activation has not been characterized and thus a mechanistic role for PKCd in the regulated proteolysis of IFNaR2 remains uncertain and represents an area for future investigation.
In addition to a sequential pattern of ligand-induced proteolysis, many RIP signaling pathways modulate gene transcription. This requires obligatory translocation of the ICD to the nucleus, as suggested by our observations on the GFP-ICD fusion in Figure 8 . Intramembrane cleavage could function to unmask a IFNaR2 receptor proteolysis AZM Saleh et al latent nuclear localization sequence within the ICD; alternatively, an interacting protein might supply such a signal. A fusion between the Gal4DBD and the IFNaR2 ICD is, indeed, able to modulate the transcription of a Gal4UAS-driven reporter. Surprisingly, the transcription of this reporter is repressed, in a dose-dependent manner, by the Gal4-I2-ICD fusion protein (Figure 9) . TSA, which can inhibit HDACs, was able to suppress the transcriptional repression effect (Figure 10 ), suggesting that one or more HDAC proteins are involved in this process. Our preliminary experiments also indicate that an isolated ICD might act similarly to repress transcription of a representative ISRE. How the ICD binds the ISRE is not yet known. The reporter construct employed in these experiments contains functional Sp1 sites (Jones et al., 1985; Kubota et al., 2001) . The Gal4-I2-ICD may recruit HDAC protein(s), which in turn deacetylates histones at the transcription complex formed around one or both of these sites.
The ICD proteins characterized thus far are quite variable in domain composition and function (Ebinu and Yanker, 2002) . One, SREBP, has both DNAbinding domain (DBD) and TAD domains and thus resembles a prototypical transcription factor. Others, exemplified by the APP ICD, appear to lack both DBD and TAD domains and function either as adaptors or to facilitate nuclear localization. Although we are uncertain what function(s) the IFNaR2 ICD itself provides, in separate experiments employing the Gal4DBD-ICD fusion (El Fiky, Arch and Krolweski, submitted), we have determined that the transcriptional effects of the IFNaR2 ICD are mediated by the TAD of Stat2, which has been shown previously to bind constitutively to the IFNaR2 ICD (Li et al., 1997; Nadeau et al., 1999; Nguyen et al., 2002; .
Although we favor the idea that proteolytic cleavage of IFNaR2 facilitates RIP signaling, there are other possible biological reasons for these events. For instance, cleavage might be part of a general mechanism for receptor protein turnover, with final degradation in the nucleus. Alternatively, cleavage might be primarily employed as a mechanism for shedding the ectodomain, thereby generating a soluble receptor, which could bind and neutralize extracellular type I IFNs and attenuate antiviral activity. Thus, while we have documented some of the key molecular events indicative of RIP signalingregulated ectodomain cleavage, constitutive intramembrane cleavage, nuclear accumulation of, and transcriptional modulation by, the ICD -further functional studies will be required to determine whether the IFNaR2 ICD mediates any of the effects of the type I IFNs.
Materials and methods
Materials
Phorbol ester (Sigma), EGF (B-D Biosciences), trichostatin A (TSA) (Biomol), H5106 (Bachem), rottlerin, bis-indolylmaleimide I (BIM) and Go¨6976 (all from Alexis), and a rabbit polyclonal antibody against the HA epitope (Santa Cruz) were used according to the respective manufacturer's directions. The anti-EF2 antibody was from K Nastiuk (University of California, IRVINE). IFN-a2 was from M Brunda (Roche) and IFN-b1A was from J Rosa (Biogen). The U2OS cell line was obtained from ATCC, the CHO cell lines stably transfected with various wild-type and mutant presenilin genes (Kimberly et al., 2000) were from D Selkoe (Harvard University Medical School) and the HEK293T cell line was from H Young (Columbia University, College of Physicians and Surgeons). The IFNaR2-deficient U5A cell line, complemented with a carboxyl-terminal HA-tagged IFNaR2 construct, has been described previously . Cells were grown in Dulbecco's modified Eagle's media (Mediatech) plus 10% fetal calf serum (Atlanta Biologicals).
DNA constructs
Plasmids encoding the following constructs have been previously described: a fusion between the GFP and the ICD of the human HER2 gene (pGFP-H2-ICD) (Ni et al., 2001) , from G Carpenter (Vanderbilt University); wild-type and kinase-deficient murine PKCd (Soh et al., 1999) , from B Weinstein (Columbia University, College of Physicians and Surgeons); a firefly luciferase gene under the control of five copies of the Gal4UAS fused to 135 bp of the Herpes Simplex virus TK promoter (pG5-TKluc) from J Chan (University of California, IRVINE) (Jones et al., 1985) ; and a constitutively expressed, TK promoter-driven Renilla luciferase gene (pRL-TK) (Promega).
A plasmid encoding a cleavable reporter derivative of IFNaR2 (pMT-I2-ECD-GV) was prepared by PCR amplifying a cassette containing the yeast Gal4 DBD fused to the VP16 TAD, incorporating NcoI and EcoR1 restriction sites at the 5 0 and 3 0 ends, respectively. The resulting fragment was sequenced and inserted into an endogenous IFNaR2 NcoI site and a flanking EcoR1 site to create a fusion construct consisting of the complete extracellular and transmembrane domains of IFNaR2, 32 amino acids of the ICD (extending to amino-acid position 299 of human IFNaR2) and a Gal4DBD-VP16TAD cassette, immediately followed by a stop codon. This fusion was transferred into the pMT2T eukaryotic expression vector. A fusion between GFP and the IFNaR2 ICD was constructed by first amplifying a carboxyl-terminal fragment containing the IFNaR2 ICD, incorporating EcoR1 restriction sites at each end. This fragment, which extends from amino acid 266 to the carboxyl terminus (residue 515) and corresponds to the region immediately distal to the predicted transmembrane domain, was cloned, sequenced, digested with EcoR1 and ligated into the pEGFP-C3 vector (Invitrogen) to produce a GFP-I2-ICD fusion. There are 11 amino acids (YSDLELKLRIR) between the EGFP sequence and the IFNaR2 ICD. To produce a fusion construct (pSGGal4DBD-I2-ICD) encoding Gal4DBD-I2-ICD, the same PCR product was digested with EcoR1, but in this case the resulting overhang was filled using the Klenow polymerase fragment and ligated into the SmaI site of pSG424 (Sadowski and Ptashne, 1989) , which encodes the Gal4DBD (residues 1-147). There are five amino acids (PELIR) between Gal4DBD codon 147 and the IFNaR2 ICD. Intact pSG242 was employed to express the Gal4DBD alone. Gal4UAS-regulated luciferase reporter gene activity was assayed using pG5-TKluc (Forman et al., 1995) , which contains five Gal4UAS-binding sites and 135 base pairs of the HSV TK gene upstream regulatory region linked to a firefly luciferase gene. To assay ISRE-regulated luciferase reporter gene activity, a fragment encoding the ISG15 ISRE was transferred from a previously described plasmid ISRE reporter (Improta and Pine, 1997) into pGL3 promoter (Promega) to create pGL3-ISRE-luc. PGL3 promoter was used as a control in these experiments.
Full-length IFNaR2 containing an HA epitope tag at the extreme carboxyl terminus was described previously . This construct was transferred into pcDNA Zeo 3.1 (À) for use in establishing the U5A stable transfectants analysed in Figure 2b and c. A construct spanning the putative ICD (residues 261-515), preceded by an initiator methionine, was prepared by PCR and cloned into pMT2T. Derivatives of IFNaR2 with deletions within the extracellular domain were prepared by PCR. For E1, PCR was used to join amino acid 220 to a FLAG-MluI epitope (DYKDDDDKTR). A second PCR amplification joined the FLAG tag to residue 45 at an EcoRV site. Thus, in E1, residues 33-219 are deleted and replaced by the indicated FLAG epitope. For E2, a similar set of PCR fragments deleted residues 33-232 and inserted residues 43-44 (EcoRV site).
Protein extracts and immunoblotting
Cells expressing IFNaR2 derivatives were either previously described , or generated by transiently transfecting HEK293T cells or stably transfecting U5A cells, followed by selection in 75 mg/ml zeocin (Invitrogen). Combined cytoplasmic and plasma membrane protein extracts were prepared from NP-40 lysed cells as described previously . Membrane preparations used in the in vitro cleavage assay were prepared essentially as described by others (Lee et al., 2002) . In brief, 8 Â 10 7 cells were lysed by repeatedly passing the appropriate cell suspension through a syringe fitted with a 23-gauge needle (25 strokes). The lysate was centrifuged at 1.5 Â 10 3 g to pellet unbroken cells and organelles. The supernatant was further centrifuged at 1.4 Â 10 4 g to pellet plasma membranes. This pellet was resuspended in a small volume, incubated at either 4 or 371 and then centrifuged at 2 Â 10 5 g. The final supernatant was used for immunoblotting. Cell fractions for immunoblotting were prepared similarly. In some cases, protein concentrations were measured, using the BCA kit (Pierce), prior to electrophoresis. Protein electrophoresis and immunoblotting were performed as described previously .
Fluorescence microscopy U2OS cells (10 4 cells in individual wells of a 12-well cluster dish) were transfected with GFP-H2-ICD or GFP-I2-ICD (0.5 mg) plasmid DNA, using 2 ml of Lipofectamine and 3 ml of PLUS reagent (Invitrogen), following the manufacturer's directions. After 1 day, cells were re-seeded on glass coverslips in 3.5 cm dishes. The next day, cells adherent to the coverslips were fixed with 4% (w/v) paraformaldehyde in phosphatebuffered saline, counterstained with 2 mg Hoechst 33258/ml and visualized under a Nikon Eclipse E600 fluorescent microscope equipped with a Spot RT digital camera and accompanying software.
Reporter gene assays
CHO or HEK293T cells, plated in six-well cluster dishes (2.3 Â 10 5 cells per well) were transfected via calcium phosphate precipitates with pMT-I2-ECD-GV (5 or 1 mg, respectively), pG4-TKluc (5 or 100 ng, respectively) and pRL-TK (15 ng or 100 pg, respectively). In some cases, HEK293T cells were also transfected with PKCd-expressing plasmids (500 ng/ well). U5A cells, plated in 24-well cluster dishes (1.2 Â 10 5 cells per well), were transfected using Lipofectamine PLUS (Invitrogen) with the 250 ng pGL3-ISRE-luc (or vector), 300 ng pMT2T-ICD (or vector) and 50 ng pRL-TK. At 2 days after transfection, cell lysates were coordinately assayed for firefly luciferase and Renilla luciferase activities using a Dual Luciferase Reagent kit (Promega), according to the manufacturer's instructions. Activity, in relative luciferase units (RLU), was calculated by dividing each determination of firefly luciferase activity by the appropriate Renilla luciferase activity value. Error bars correspond to the standard error of the mean. For experiments employing U2OS cells, 10 cm dishes containing 4-6 Â 10 5 cells were transfected via calcium phosphate precipitates, with either pSG424 (expressing Gal4DBD), or pSG-Gal4-I2-ICD (expressing Gal4DBD fused to the IFNaR2 ICD) (5-10 mg), pG4-TKluc (5-10 mg) and a constitutively expressed b-galactosidase gene (10 mg). Activity in RLU was calculated as above, using firefly luciferase and b-galactosidase activities.
